Capital International Inc’s Core Laboratories CLB Stock Holding History

Capital International Inc’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,136	Closed	-$216K	–	227
2019 Q2	$216K	Buy	4,136 +3,030	+274%	+$178K	0.02%	205
2019 Q1	$76K	Sell	1,106 -673	-38%	-$45.1K	0.01%	181
2018 Q4	$106K	Buy	1,779 +434	+32%	+$37.5K	0.01%	176
2018 Q3	$156K	Buy	+1,345	New	+$152K	0.02%	172
2018 Q1	–	Sell	-9,400	Closed	-$1.03M	–	167
2017 Q4	$1.03M	Sell	9,400 -10,500	-53%	-$1.05M	0.15%	102
2017 Q3	$1.96M	Sell	19,900 -4,100	-17%	-$397K	0.29%	76
2017 Q2	$2.43M	Sell	24,000 -10,352	-30%	-$1.12M	0.35%	70
2017 Q1	$3.97M	Sell	34,352 -14,300	-29%	-$1.66M	0.48%	54
2016 Q4	$5.84M	Buy	+48,652	New	+$5.39M	0.73%	35

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Inc's CLB Position: Q3 2019 in Review

Capital International Inc sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 4,136 shares — an estimated $216K sold.

Capital International Inc first reported a position in CLB in Q4 2016 and held it in 9 quarters. The position peaked at $5.84M in Q4 2016. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

Capital International Inc reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
Capital International Inc sold 4,136 Core Laboratories shares in Q3 2019, an estimated $216K.
Capital International Inc first reported a position in Core Laboratories in Q4 2016 and held it in 9 quarters.
Capital International Inc's Core Laboratories position peaked at $5.84M in Q4 2016.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Capital International Inc's 13F filing for Q3 2019, filed 14 Nov 2019.